Health Care/Hospital
Dr. Reddy's and GRA Announce Clinically Meaningful Data from Avigan Pivotal Studies
Sub-group analysis shows three-day earlier discharge from hospital in low-risk patients hospitalized with COVID-19 KUWAIT CITY, Jan. 28, 2021 /PRNewswire/ -- Dr. Reddy's Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) (NSEIFSC: DRREDDY along with its subsidiaries together referred to ...
2021-01-28 03:57
1932
Transnetyx, One Codex Build Strategic Partnership to Provide a Complete Microbiome Analysis Service for Both Mice and Humans
MEMPHIS, Tenn., Jan. 27, 2021 /PRNewswire/ -- Transnetyx, Inc. announced today its collaboration with One Codex on an end-to-end microbiome sequencing and analysis service. This offering will be driven by Transnetyx's wide-reaching global footprint in the model organism community and One Codex's ...
2021-01-28 03:29
1107
Valcare Medical Announces First-in-Human Transseptal Implant of the AMEND™ Annuloplasty Ring for Mitral Valve Repair
HERZLIYA, Israel, Jan. 28, 2021 /PRNewswire/ -- Valcare Medical Ltd. developer of transcatheter mitral and tricuspid valve repair and replacement solutions, announces that it has successfully completed its first-in-human transseptal delivery of the AMEND™ annuloplasty ring. The transseptal AMEND ...
2021-01-28 02:04
2241
Neurophth Therapeutics Further Expands Ocular Gene Therapy Expertise with Appointment of Qiutang Li, Ph.D., as Chief Scientific Officer
WUHAN, China and NEWARK, Del., Jan. 27, 2021 /PRNewswire/ -- Wuhan Neurophth Biotechnology Ltd., a fully-integrated genetic medicines company developing AAV-delivered gene therapies for the treatment of ocular diseases, today announced the appointment of Qiutang Li, Ph.D., as Chief Scientific Off...
2021-01-27 21:00
1321
Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study
SAN DIEGO and BURLINGAME, California, Jan. 27, 2021 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, and Humanigen, Inc. (NASDAQ: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical compa...
2021-01-27 20:00
4517
"Ping An Good Doctor" APP Officially Gets Renamed "Ping An Health" to Focus on Medical + Healthcare
HONG KONG, Jan. 27, 2021 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (stock code: 1833.HK), a leading internet healthcare services platform inChina, announced that, in line with the Company's comprehensive strategic upgrade, the "Ping An Good Doctor" APP was officially renam...
2021-01-27 19:42
5022
MINISO Donates Over 2 Million Masks to North American Non-Profit Organizations and Colleges
GUANGZHOU, China, Jan. 27, 2021 /PRNewswire/ -- As part of its campaign in the fight against the COVID-19 pandemic, branded variety retailer MINISO (NYSE: MNSO) has donated more than 1 million masks to Get Us PPE and over 10,000 masks to colleges around the U.S. The masks will aid in protecting f...
2021-01-27 19:30
6126
Singapore-based Osteopore International Collaborates With Maastricht University Medical Centre To Develop Implant Solution That Prevents Leg Amputations
* Osteopore and Maastricht University Medical Centre has developed a first-of-its-kind, bioresorbable bone implant solution that prevents leg amputations in patients with severe lower leg fractures * Osteopore and National Additive Manufacturing Innovation Cluster have formed a partnership to...
2021-01-27 17:57
1412
Medeon Announces Positive Clinical Results for XFLO Minimally Invasive BPH Treatment Device
TAIPEI, Jan. 27, 2021 /PRNewswire/ -- Medeon Biodesign, Inc. (TPEx: 6499), a Taiwan publicly traded medical device company, is pleased to announce positive interim results of the EXPANDER-1 Clinical Study for its flagship product the XFLO™ Expander System, an innovative, minimally invasive Benign...
2021-01-27 17:41
1584
Bill and Melinda Gates Release 2021 Annual Letter: "The Year Global Health Went Local"
SEATTLE, Jan. 27, 2021 /PRNewswire/ -- Today, Bill and Melinda Gates share their 2021 Annual Letter, "The Year Global Health Went Local." In this year's letter, Bill and Melinda reflect on the worldwide impact of COVID-19 and the global collaboration and scientific innovation fueling one of the la...
2021-01-27 16:00
1653
AXA Hong Kong and Macau stands with Employee Benefits customers in the new normal under COVID-19 by providing free new physical and mental protection
HONG KONG, Jan. 27, 2021 /PRNewswire/ -- As the COVID-19 pandemic continues, AXA Hong Kong andMacau today announced the launch of a series of free new physical and mental health protection and services for all Employee Benefits customers, supporting corporates and their employees in this critical...
2021-01-27 15:49
1953
South Korean Medical AI Provider and PACS Leader Enters Indonesian Market, to Help COVID-19 Screening and Diagnosis
SEOUL, South Korea, Jan. 27, 2021 /PRNewswire/ -- Lunit, a South Korean medical
AI software company, announced a partnership with a leading PACS provider
INFINITT Healthcare to accelerate its global expansion.
2021-01-27 15:37
1798
Casio to Release DERMOCAMERA™, Allowing Dermatologists to Capture Close-up and Ordinary Shots of Affected Areas Using a Single Device
TOKYO, Jan. 27, 2021 /PRNewswire/ -- Casio Computer Co., Ltd. announced today the upcoming release of the DZ-D100 DERMOCAMERA that allows close-up shots with the lens directly touching the skin as well as ordinary shots, all using a single camera. The new product was created based on collaborativ...
2021-01-27 12:21
1720
Sihuan Pharmaceutical (0460.HK): Xuanzhu Biopharm acquires Combio Pharmaceutical, the large-molecule integrated development platform helps drive innovation
HONG KONG, Jan. 27, 2021 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as the "Group"; Hong Kong Stock Exchange Stock Code: 0460) is pleased to announce its innovation Xuanzhu Biopharma...
2021-01-27 11:21
6206
Speedy Detection of 13 Cancer Types using a Tiny Amount of Blood: microRNA Detection Technology
SINGAPORE, Jan. 27, 2021 /PRNewswire/ -- Globally, about 1 in 6 deaths is due to cancer. With advances in treatment, early detection and treatment of cancer greatly improves survival rates of patients. Find out how Toshiba's microRNA detection technologies contribute to cancer detection at an ult...
2021-01-27 10:00
18779
Kingston x CSD Reveals APAC Top 10 heartwarming face mask designs
* Over 3,100 entries received across all APAC regions for Kingston x CSD APAC Mask Design Competition as artists induce positivity through mask designs, share compelling life stories and reflections on 2020 * Vote online now for the favourite finalist and decide who the winner will be TAIPEI, ...
2021-01-27 10:00
2386
TUV Rheinland: Better through the pandemic with systematic occupational health and safety
COLOGNE, Germany, Jan. 27, 2021 /PRNewswire/ -- With a systematic management of occupational health and safety, companies are better prepared for the challenges of the Corona pandemic. The standard for occupational health and safety management - ISO 45001 - leads to a faster and more systematic a...
2021-01-27 09:00
1913
Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA
INCHEON, South Korea, Jan. 26, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy, furthering the company's track record as a premiere CDO serv...
2021-01-27 08:26
5872
Biocytogen Subsidiary Eucure Biopharma Reports First Patient Enrolled in anti-CTLA4 Phase I Trial in China
BOSTON and BEIJING, Jan. 26, 2021 /PRNewswire/ -- Eucure Biopharma, a subsidiary of Biocytogen, announced the first patient enrollment for a Phase I clinical trial inChina to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of its anti-CTLA4 monoclonal antibody (YH001)...
2021-01-26 23:45
1102
Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta
MONTREAL, Jan. 26, 2021 /PRNewswire/ -- Caprion-HistoGeneX, a leading global
provider of specialized precision medicine laboratory services to the
biopharmaceutical industry, is pleased to announce its new corporate name,
CellCarta, and brand identity.
2021-01-26 21:23
2517
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
9174
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
2024-04-18 21:26
8847
Animated Life in Yunnan
2024-04-18 14:00
7831
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7752